Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
BMC Psychiatry
Published in: BMC Psychiatry 1/2017

Open Access 01-12-2017 | Study protocol

Cognitive-behavioral treatment with behavioral activation for smokers with depressive symptomatology: study protocol of a randomized controlled trial

Authors: Elisardo Becoña, Carmela Martínez-Vispo, Carmen Senra, Ana López-Durán, Rubén Rodríguez-Cano, Elena Fernández del Río

Published in: BMC Psychiatry | Issue 1/2017

Login to get access

Abstract

Background

Smoking is an important risk factor for mental health-related problems. Numerous studies have supported a bi-directional association between cigarette smoking and depression. Despite the advances in understanding the comorbidity between both problems, the most effective psychological treatment that simultaneously targets smoking and depressive symptomatology remains unclear. The objective of this study is to assess the effectiveness of a cognitive-behavioral intervention for smoking cessation with components of behavioral activation for managing depressed mood.

Method

A single blind, three-arm, superiority randomized controlled trial is proposed. Participants will be smokers over 18 years old, who smoke at least 8 cigarettes per day. Participants will be randomized to one of three conditions, using a 2:2:1 allocation ratio: 1) standard cognitive-behavioral smoking cessation treatment; 2) standard cognitive-behavioral smoking cessation treatment plus behavioral activation; or 3) a three-month delayed treatment control group. The primary outcome measures will be biochemically verified point-prevalence abstinence (carbon monoxide in expired air) and significant change from baseline in depressive symptoms to the end of treatment, and at the 3-, 6-, and 12-month follow-up.

Discussion

This study aims to assess the efficacy of a cognitive-behavioral intervention with behavioral activation components for smoking cessation and depressive symptoms, compared to a standard cognitive-behavioral intervention to quit smoking. As the relation between depressive symptoms, even at subclinical levels, and quitting smoking difficulties is well known, we expect that such intervention will allow obtaining higher abstinence rates, lower relapse rates, and mood improvement.

Trial registration

ClinicalTrials.​gov: NCT02844595. Retrospectively registered 19th July, 2016. The study started in January 2016, and the recruitment is ongoing.
Literature
1.
Carter BD, Abnet CC, Feskanich D, Freedman ND, Hartge P, Lewis CE, et al. Smoking and mortality - beyond established causes. N Engl J Med. 2015;372(7):631–40.CrossRefPubMed
2.
U. S. Department of Health and Human Services, Public Health Services O of the SG. The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General, 2014. Rockville; 2014.
3.
4.
Leventhal AM, Japuntich SJ, Piper ME, Jorenby DE, Schlam TR, Baker TB. Isolating the role of psychological dysfunction in smoking cessation: relations of personality and psychopathology to attaining cessation milestones. Psychol Addict Behav. 2012;26(4):838–49.CrossRefPubMedPubMedCentral
5.
Weinberger AH, Pilver CE, Desai RA, Mazure CM, McKee SA. The relationship of dysthymia, minor depression, and gender to changes in smoking for current and former smokers: longitudinal evaluation in the U.S. population. Drug Alcohol Depend. 2013;127(1–3):170–6.CrossRefPubMed
6.
Lawrence D, Mitrou F, Zubrick SR. Smoking and mental illness: results from population surveys in Australia and the United States. BMC Public Health. 2009;9:285.CrossRefPubMedPubMedCentral
7.
Shahab L, Andrew S, West R. Changes in prevalence of depression and anxiety following smoking cessation: results from an international cohort study (ATTEMPT). Psychol Med. 2014;44(1):127–41.CrossRefPubMed
8.
Strine TW, Mokdad AH, Balluz LS, Gonzalez O, Crider R, Berry JT, et al. Depression and anxiety in the United States: findings from the 2006 behavioral risk factor surveillance system. Psychiatr Serv. 2008;59(12):1383–90.CrossRefPubMed
9.
Bakhshaie J, Zvolensky MJ, Goodwin RD. Cigarette smoking and the onset and persistence of depression among adults in the United States: 1994–2005. Compr Psychiatry. 2015 Jul;60:142–8.CrossRefPubMed
10.
Piper ME, Smith SS, Schlam TR, Fleming MF, Bittrich AA, Brown JL, et al. Psychiatric disorders in smokers seeking treatment for tobacco dependence: relations with tobacco dependence and cessation. J Consult Clin Psychol. 2010;78(1):13–23.CrossRefPubMedPubMedCentral
11.
Reid HH, Ledgerwood DM. Depressive symptoms affect changes in nicotine withdrawal and smoking urges throughout smoking cessation treatment: preliminary results. Addict Res Theory. 2016;24(1):48–53.CrossRefPubMed
12.
Weinberger AH, Kashan RS, Shpigel DM, Esan H, Taha F, Lee CJ, et al. Depression and cigarette smoking behavior: a critical review of population-based studies. Am J Drug Alcohol Abuse. 2016;2990:1–16.CrossRef
13.
Zvolensky MJ, Bakhshaie J, Sheffer C, Perez A, Goodwin RD. Major depressive disorder and smoking relapse among adults in the United States: a 10-year, prospective investigation. Psychiatry Res. 2015;226(1):73–7.CrossRefPubMed
14.
Niaura R, Britt DM, Shadel WG, Goldstein M, Abrams D, Brown R. Symptoms of depression and survival experience among three samples of smokers trying to quit. Psychol Addict Behav. 2001;15(1):13–7.CrossRefPubMed
15.
Blalock JA, Robinson JD, Wetter DW, Schreindorfer LS, Cinciripini PM. Nicotine withdrawal in smokers with current depressive disorders undergoing intensive smoking cessation treatment. Psychol Addict Behav. 2008;22(1):122–8.CrossRefPubMed
16.
Prochaska JJ, Hall SM, Tsoh JY, Eisendrath S, Rossi JS, Redding CA, et al. Treating tobacco dependence in clinically depressed smokers: effect of smoking cessation on mental health functioning. Am J Public Health. 2008;98(3):446–8.CrossRefPubMedPubMedCentral
17.
Rodríguez-Cano R, López-Durán A, Del Río EF, Martínez-Vispo C, Martínez Ú, Becoña E. Smoking cessation and depressive symptoms at 1-, 3-, 6-, and 12-months follow-up. J Affect Disord. 2016;191
18.
Taylor G, McNeill A, Girling A, Farley A, Lindson-Hawley N, Aveyard P. Change in mental health after smoking cessation: systematic review and meta-analysis. BMJ Open. 2014;348:g1151.CrossRef
19.
Siu AL. Behavioral and pharmacotherapy interventions for tobacco smoking cessation in adults, including pregnant women: U.S. preventive services task force recommendation statement. Ann Intern Med. 2015;163(8):622–34.CrossRefPubMed
20.
Becoña E, López-Durán A, Fernández del Río E, Martínez Ú. Changes in the profiles of smokers seeking cessation treatment and in its effectiveness in Galicia (Spain) 2001–10. BMC Public Health. 2014;14(1):613.CrossRefPubMedPubMedCentral
21.
Irvin JE, Brandon TH. The increasing recalcitrance of smokers in clinical trials. Nicotine Tob Res. 2000;2(1):79–84.CrossRefPubMed
22.
Irvin J, Hendricks P, Brandon T. The increasing recalcitrance of smokers in clinical trials II: pharmacotherapy trials. Nicotine Tob Res. 2003;5(1):27–35.CrossRefPubMed
23.
Leyro TM, Crew EE, Bryson SW, Lembke A, Bailey SR, Prochaska JJ, et al. Retrospective analysis of changing characteristics of treatment-seeking smokers: implications for further reducing smoking prevalence. BMJ Open. 2016;6(6):e010960.CrossRefPubMedPubMedCentral
24.
Gierisch JM, Bastian LA, Calhoun PS, McDuffie JR, Williams JW. Smoking cessation interventions for patients with depression: a systematic review and meta-analysis. J Gen Intern Med. 2012;27(3):351–60.CrossRefPubMed
25.
van der Meer RM, Willemsen MC, Smit F, Cuijpers P, R.M. van der Meer, M.C. Willemsen, et al. Smoking cessation interventions for smokers with current or past depression. Cochrane Database Syst Rev 2013;8(8):CD006102.
26.
Ekers D, Webster L, Van Straten A, Cuijpers P, Richards D, Gilbody S. Behavioural activation for depression; an update of meta-analysis of effectiveness and sub group analysis. PLoS One. 2014;9(6):e100100.CrossRefPubMedPubMedCentral
27.
Jacobson NS, Dobson KS, Truax PA, Addis ME, Koerner K, Gollan JK, et al. A component analysis of cognitive-behavioral treatment for depression. J Consult Clin Psychol. 1996;64(2):295–304.CrossRefPubMed
28.
Richards DA, Ekers D, McMillan D, Taylor RS, Byford S, Warren FC, et al. Cost and outcome of Behavioural activation versus cognitive Behavioural therapy for depression (COBRA): a randomised, controlled, non-inferiority trial. Lancet. 2016;388(10047):871–80.CrossRefPubMedPubMedCentral
29.
Martell CR, Dimidjian S, Herman-Dunn R. Behavioral activation for depression : a clinician’s guide: Guilford Press; 2010. 220 p.
30.
Audrain-McGovern J, Wileyto EP, Ashare R, Cuevas J, Strasser AA. Reward and affective regulation in depression-prone smokers. Biol Psychiatry. 2014 Nov;76(9):689–97.CrossRefPubMedPubMedCentral
31.
Macpherson L, Tull MT, Matusiewicz AK, Rodman S, Strong DR, Kahler CW. Randomized controlled trial of behavioral activation smoking cessation treatment for smokers with elevated depressive symptoms. J Consult Clin Psychol. 2010;78(1):55–61.CrossRefPubMedPubMedCentral
32.
Banducci AN, Long KE, MacPherson L. A case series of a behavioral activation−enhanced smoking cessation program for inpatient substance users with elevated depressive symptoms. Clin Case Stud. 2015 Feb;14(1):61–77.CrossRef
33.
Mottillo S, Filion KB, Belisle P, Joseph L, Gervais A, O’Loughlin J, et al. Behavioural interventions for smoking cessation: a meta-analysis of randomized controlled trials. Eur Heart J. 2008;30(6):718–30.CrossRefPubMed
34.
Faul F, Erdfelder E, Lang A-G, Buchner A. G*power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39(2):175–91.CrossRefPubMed
35.
Becoña E. Evaluación de la conducta de fumar [Assessment of smoking behavior]. In: Graña JL, editor. Conductas Adictivas: Teoría, evaluación y tratamiento. Madrid: Debate; 1994. p. 403–54.
36.
Fagerstrom K. Determinants of tobacco use and renaming the FTND to the Fagerstrom test for cigarette dependence. Nicotine Tob Res. 2012;14(1):75–8.CrossRefPubMed
37.
Fagerström K, Furberg H. A comparison of the Fagerström test for nicotine dependence and smoking prevalence across countries. Addiction. 2008;103(5):841–5.CrossRefPubMedPubMedCentral
38.
Becoña, E. y Lorenzo MC. Evaluación de la conducta de fumar. Adicciones 2004;16(2):201–226.
39.
Shiffman S, Waters A, Hickcox M. The nicotine dependence syndrome scale: a multidimensional measure of nicotine dependence. Nicotine Tob Res. 2004;6(2):327–48.CrossRefPubMed
40.
Becoña E, López A. Fernández del Río E, Míguez MC, Castro J. Spanish adaptation of the NDSS (nicotine dependence syndrome scale) and assessment of nicotine-dependent individuals at primary care health centers in Spain. Span J Psychol. 2010;13(2):951–60.CrossRefPubMed
41.
Hughes JR, Hatsukami D. Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry. 1986;43(3):289–94.CrossRefPubMed
42.
Muñoz R. Preventing major depression by promoting emotion regulation: a conceptual framework and some practical tools. Int J Ment Health Promot. 1998;1:23–40.
43.
Beck A, Steer R, Brown G. Beck depression inventory. Texas. San Antonio: The Cognitive-Behavioral Corporation; 1996.
44.
Sanz J, Vazquez C. Adaptación española del Inventario para Depresión de Beck-II (BDI-II) [Spanish adaptation of the Beck depression inventory—II (BDI-II)]. Manual. Madrid: Pearson; 2011.
45.
46.
Ramos-Brieva JA, Cordero A. Validación de la versión castellana de la Escala de Hamilton para la Depresión [validation of the Spanish version of the Hamilton depression rating scale]. Actas Luso Españolas Neurol Psiquiatr y Ciencias Afines. 1986;14:324–34.
47.
Armento MEA, Hopko DR. The environmental reward Observation scale (EROS): development, validity, and reliability. Behav Ther. 2007 Jun;38(2):107–19.CrossRefPubMed
48.
Barraca J, Pérez-Álvarez M. Adaptación española de la Environmental Reward Observation Scale (EROS). Ansiedad Estrés. 2010;16(1):95–107.
49.
Kanter JW, Mulick PS, Busch AM, Berlin KS, Martell CR. The behavioral activation for depression scale (BADS): psychometric properties and factor structure. J Psychopathol Behav Assess. 2007;29(3):191–202.CrossRef
50.
Barraca J, Pérez-Álvarez M, Bleda JHL. Avoidance and activation as keys to depression: adaptation of the behavioral activation for depression scale in a Spanish sample. Span J Psychol. 2011;14(2):998–1009.CrossRefPubMed
51.
Nolen-Hoeksema S, Larson J, Grayson C. Explaining the gender difference in depressive symptoms. J Pers Soc Psychol. 1999;77(5):1061–72.CrossRefPubMed
52.
Hervás G. Adaptación al castellano de un instrumento para evaluar el estilo rumiativo: la escala de respuestas rumiativas. Rev psicopatología y Psicol clínica. 2008;13(2):111–21.
53.
Treynor W, Gonzalez R, Nolen-Hoeksema S. Rumination reconsidered: a psychometric analysis. Cognitive therapy and research. Cognit Ther Res. 2003;27(3):247–59.CrossRef
54.
Russell DW. UCLA loneliness scale (version 3): reliability, validity, and factor structure. J Pers Assess. 1996;66(1):20–40.CrossRefPubMed
55.
Expósito F, Moya Morales MC. Soledad y apoyo social. Rev Psicol Soc. 1999;14(2):297–316.CrossRef
56.
West R, Hajek P, Stead L, Stapleton J. Outcome criteria in smoking cessation trials: proposal for a common standard. Addiction. 2005;100(3):299–303.CrossRefPubMed
57.
Becoña E. Programa para dejar de fumar [Smoking cessation program]. Nova Galicia Edicións: Vigo; 2007.
58.
Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol. 2010;63(8):e1–37.CrossRefPubMed
59.
Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med. 2010;152(11):726–32.CrossRefPubMed
60.
Chan A-W, Tetzlaff JM, Altman DG, Laupacis A, Gøtzsche PC, Krleža-Jerić K, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013 Feb 5;158(3):200.CrossRefPubMedPubMedCentral
61.
Chan A-W, Tetzlaff JM, Gøtzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. Br Med J. 2013;346(346):e7586.CrossRef
Metadata
Title
Cognitive-behavioral treatment with behavioral activation for smokers with depressive symptomatology: study protocol of a randomized controlled trial
Authors
Elisardo Becoña
Carmela Martínez-Vispo
Carmen Senra
Ana López-Durán
Rubén Rodríguez-Cano
Elena Fernández del Río
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Psychiatry / Issue 1/2017
Electronic ISSN: 1471-244X
DOI
https://doi.org/10.1186/s12888-017-1301-7

Other articles of this Issue 1/2017

BMC Psychiatry 1/2017 Go to the issue

Research article

Psychosocial stressors contributing to emergency psychiatric service utilization in a sample of ethno-culturally diverse clients with psychosis in Toronto

Research article

Enrichment activities in the medical school psychiatry programme – could this be a key to engaging medical students in psychiatry? A study from a high secure forensic psychiatric UK hospital

Research article

A randomized, double-blind, placebo-controlled trial on the role of preemptive analgesia with acetaminophen [paracetamol] in reducing headache following electroconvulsive therapy [ECT]

Research article

Relevance of a subjective quality of life questionnaire for long-term homeless persons with schizophrenia

Case report

Duloxetine-induced rapid eye movement sleep behavior disorder: a case report

Research article

Barriers and facilitators in accessing dementia care by ethnic minority groups: a meta-synthesis of qualitative studies